Definitive Healthcare Net Worth
Definitive Healthcare Net Worth Breakdown | DH |
Definitive Healthcare Net Worth Analysis
Definitive Healthcare's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Definitive Healthcare's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Definitive Healthcare's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Definitive Healthcare's net worth analysis. One common approach is to calculate Definitive Healthcare's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Definitive Healthcare's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Definitive Healthcare's net worth. This approach calculates the present value of Definitive Healthcare's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Definitive Healthcare's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Definitive Healthcare's net worth. This involves comparing Definitive Healthcare's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Definitive Healthcare's net worth relative to its peers.
Enterprise Value |
|
To determine if Definitive Healthcare is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Definitive Healthcare's net worth research are outlined below:
Definitive Healthcare generated a negative expected return over the last 90 days | |
Definitive Healthcare has high historical volatility and very poor performance | |
Definitive Healthcare has a very high chance of going through financial distress in the upcoming years | |
The company generated the yearly revenue of 252.2 M. Annual Net Loss to common stockholders was (591.45 M) with gross profit of 211.52 M. | |
Over 97.0% of the company shares are held by institutions such as insurance companies | |
Latest headline from thelincolnianonline.com: 287,409 Shares in Definitive Healthcare Corp. Purchased by Susquehanna Fundamental Investments LLC |
Definitive Healthcare Quarterly Good Will |
|
Definitive Healthcare uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Definitive Healthcare Corp. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Definitive Healthcare's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
22nd of February 2024 Upcoming Quarterly Report | View | |
2nd of May 2024 Next Financial Report | View | |
31st of December 2023 Next Fiscal Quarter End | View | |
22nd of February 2024 Next Fiscal Year End | View | |
30th of September 2023 Last Quarter Report | View | |
31st of December 2022 Last Financial Announcement | View |
Know Definitive Healthcare's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Definitive Healthcare is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Definitive Healthcare Corp backward and forwards among themselves. Definitive Healthcare's institutional investor refers to the entity that pools money to purchase Definitive Healthcare's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares | Morgan Stanley - Brokerage Accounts | 2024-12-31 | 775.6 K | Millennium Management Llc | 2024-12-31 | 772.9 K | New York State Common Retirement Fund | 2024-12-31 | 771.8 K | D. E. Shaw & Co Lp | 2024-12-31 | 709.8 K | B. Riley Asset Management, Llc | 2024-12-31 | 677.9 K | Bank Of America Corp | 2024-12-31 | 617.5 K | Renaissance Technologies Corp | 2024-12-31 | 579.4 K | Citadel Advisors Llc | 2024-12-31 | 524.1 K | Northern Trust Corp | 2024-12-31 | 497.3 K | Advent International Lp | 2024-12-31 | 62.5 M | Irenic Capital Management Lp | 2024-12-31 | 7 M |
Follow Definitive Healthcare's market capitalization trends
The company currently falls under 'Small-Cap' category with a market capitalization of 306.61 M.Market Cap |
|
Project Definitive Healthcare's profitablity
Last Reported | Projected for Next Year | ||
Return On Tangible Assets | (1.04) | (0.99) | |
Return On Capital Employed | (0.77) | (0.73) | |
Return On Assets | (0.38) | (0.36) | |
Return On Equity | (0.93) | (0.88) |
When accessing Definitive Healthcare's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Definitive Healthcare's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Definitive Healthcare's profitability and make more informed investment decisions.
Evaluate Definitive Healthcare's management efficiency
The Definitive Healthcare's current Return On Tangible Assets is estimated to increase to -0.99. The Definitive Healthcare's current Return On Capital Employed is estimated to increase to -0.73. As of now, Definitive Healthcare's Fixed Asset Turnover is decreasing as compared to previous years. The Definitive Healthcare's current Asset Turnover is estimated to increase to 0.24, while Net Tangible Assets are projected to decrease to (682 M). Definitive Healthcare's management efficiency ratios could be used to measure how well Definitive Healthcare manages its routine affairs as well as how well it operates its assets and liabilities.Last Reported | Projected for Next Year | ||
Book Value Per Share | 5.21 | 4.95 | |
Tangible Book Value Per Share | (0.72) | (0.76) | |
Enterprise Value Over EBITDA | (1.11) | (1.05) | |
Price Book Value Ratio | 1.08 | 1.02 | |
Enterprise Value Multiple | (1.11) | (1.05) | |
Price Fair Value | 1.08 | 1.02 | |
Enterprise Value | 627.1 M | 595.8 M |
Examining the leadership quality of Definitive Healthcare Corp offers valuable insights into its operational efficiency and financial health. This analysis assists investors in making informed decisions regarding the stock.
Enterprise Value Revenue 1.0688 | Revenue | Quarterly Revenue Growth (0.06) | Revenue Per Share | Return On Equity |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Definitive Healthcare insiders, such as employees or executives, is commonly permitted as long as it does not rely on Definitive Healthcare's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Definitive Healthcare insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Definitive Healthcare Corporate Filings
F4 | 29th of April 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
23rd of April 2025 Other Reports | ViewVerify | |
F3 | 4th of March 2025 The report used by insiders such as officers, directors, and major shareholders (beneficial owners holding more than 10% of any class of the company's equity securities) to declare their ownership of a company's stock | ViewVerify |
8K | 27th of February 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
Definitive Healthcare Earnings per Share Projection vs Actual
Definitive Healthcare Corporate Management
Jon Maack | President | Profile | |
Mary Delano | Senior Sciences | Profile | |
Matt Ruderman | Chief Secretary | Profile | |
David Kronfeld | Chief Officer | Profile | |
Richard CPA | Chief Officer | Profile | |
Marissa Odell | Senior Diversified | Profile | |
Rebecca Marani | Senior Provider | Profile |
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Definitive Healthcare Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Is Health Care Technology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Definitive Healthcare. If investors know Definitive will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Definitive Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.54) | Revenue Per Share | Quarterly Revenue Growth (0.06) | Return On Assets | Return On Equity |
The market value of Definitive Healthcare is measured differently than its book value, which is the value of Definitive that is recorded on the company's balance sheet. Investors also form their own opinion of Definitive Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Definitive Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Definitive Healthcare's market value can be influenced by many factors that don't directly affect Definitive Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Definitive Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Definitive Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Definitive Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.